These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China. Feng JG, Guo Y, Ma LA, Xing J, Sun RF, Zhu W. J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857 [Abstract] [Full Text] [Related]
7. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF. J Clin Endocrinol Metab; 2000 Jul; 85(7):2434-8. PubMed ID: 10902790 [Abstract] [Full Text] [Related]
11. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. J Clin Endocrinol Metab; 1998 Sep; 83(9):3078-82. PubMed ID: 9745406 [Abstract] [Full Text] [Related]
12. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome. Pavičić Baldani D, Škrgatić L, Bukvić Mokos Z, Trgovčić I. Acta Dermatovenerol Croat; 2013 Sep; 21(2):105-12. PubMed ID: 24001418 [Abstract] [Full Text] [Related]
13. Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome. Zore T, Lizneva D, Brakta S, Walker W, Suturina L, Azziz R. Fertil Steril; 2019 Feb; 111(2):389-396. PubMed ID: 30527835 [Abstract] [Full Text] [Related]
14. Acne severity and the Global Acne Grading System in polycystic ovary syndrome. Hacivelioglu S, Gungor AN, Gencer M, Uysal A, Hizli D, Koc E, Cosar E. Int J Gynaecol Obstet; 2013 Oct; 123(1):33-6. PubMed ID: 23948280 [Abstract] [Full Text] [Related]
15. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome. Amato MC, Galluzzo A, Finocchiaro S, Criscimanna A, Giordano C. Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780 [Abstract] [Full Text] [Related]
16. Characteristics of 250 reproductive-aged polycystic ovary syndrome Thai women at Siriraj Hospital. Wongwananuruk T, Indhavivadhana S, Rattanachaiyanont M, Techatraisak K, Leerasiri P, Tanmahasamut P, Angsuwathana S, Dangrat C. J Med Assoc Thai; 2010 Apr; 93(4):399-405. PubMed ID: 20462080 [Abstract] [Full Text] [Related]
17. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI. J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641 [Abstract] [Full Text] [Related]
18. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective. Pasquali R, Zanotti L, Fanelli F, Mezzullo M, Fazzini A, Morselli Labate AM, Repaci A, Ribichini D, Gambineri A. J Clin Endocrinol Metab; 2016 May; 101(5):2013-22. PubMed ID: 26964728 [Abstract] [Full Text] [Related]
19. Association between biochemical hyperandrogenism parameters and Ferriman-Gallwey score in patients with polycystic ovary syndrome: A systematic review and meta-regression analysis. Amiri M, Ramezani Tehrani F, Nahidi F, Bidhendi Yarandi R, Behboudi-Gandevani S, Azizi F. Clin Endocrinol (Oxf); 2017 Sep; 87(3):217-230. PubMed ID: 28575537 [Abstract] [Full Text] [Related]